Education Background
Kajuluri’s educational journey began with a Bachelor of Science in Biotechnology, Biochemistry, and Chemistry from Andhra University in 2007. He continued to pursue a Master of Science in Biotechnology from Andhra University, followed by a Ph.D. in Science from CSIR-Central Drug Research Institute, India. His academic excellence has paved the way for several postdoctoral positions, starting from his research fellowship at Boston University to his current position at Massachusetts General Hospital, where he continues to explore novel therapies in cardiovascular research. 🎓📚
Professional Experience
Kajuluri’s professional career began as a Research Fellow at CSIR-Central Drug Research Institute in India, focusing on Leishmaniasis and actin-related proteins. He transitioned to postdoctoral research at Boston University, where he led studies on vascular smooth muscle contraction and calponin. His current role as a Postdoctoral Research Fellow at MGH involves leading studies on vascular calcification, gene therapy, and identifying therapeutic targets to treat cardiovascular diseases. His extensive research in these areas contributes significantly to the advancement of vascular health. 🔬🧑🔬
Awards and Honors
Kajuluri has received numerous prestigious awards throughout his career. Notably, he was awarded the Research Fellowship from the University Grants Commission, New Delhi, India (2011-2016). He has also been a part of several funded research projects, including those supported by the National Heart, Lung, and Blood Institute, USA. His dedication to advancing cardiovascular and infectious disease research has earned him recognition from the scientific community. 🏆🎖️
Research Focus
Kajuluri’s research is focused on understanding the molecular mechanisms underlying vascular calcification, a condition that contributes to cardiovascular diseases. His current studies explore gene therapies to treat vascular calcification in infants, as well as the role of histone deacetylases in vascular health. Additionally, his earlier work in Leishmaniasis has expanded his expertise to parasitology and cellular biology. His work bridges cardiovascular research and therapeutic innovation, offering potential treatments for critical vascular conditions. ❤️🧬
Conclusion
Lova Prasadareddy Kajuluri’s career is a testament to his commitment to advancing science in cardiovascular health and infectious diseases. Through his research, he continues to provide invaluable insights into vascular calcification and gene therapy, offering hope for future treatments in these fields. 🌟🔬
Publication Top Notes
Epigenetic Regulation of Human Vascular Calcification. Genes, 2025, 16, 506. DOI
Calponin 1 inhibits agonist-induced ERK activation and decreases calcium sensitization in vascular smooth muscle. Journal of Cellular and Molecular Medicine, January 28, 2024. PubMed
Treatment of calcific arterial disease via enhancement of autophagy using GSK343. iScience, October 28, 2023. PubMed
Intracellular localization of MyosinXXI discriminates Leishmania spp and Leptomonas seymouri. Biochemical and Biophysical Research Communications, May 14, 2022. PubMed
Actin-related protein 4: An unconventional negative regulator of mitochondrial calcium in protozoan parasite Leishmania. Mitochondrion, Jan 2022. PubMed
Vascular aging, the vascular cytoskeleton and aortic stiffness. Exploration of Medicine, June 2021. PubMed
The uterine myocyte, contractile machinery and proteins of the myometrium and their relationship to the dynamic nature of myometrial function. Current Opinion in Physiology, February 2020. ScienceDirect
A twinfilin-like protein coordinates karyokinesis by influencing mitotic spindle elongation and DNA replication in Leishmania. Molecular Microbiology, April 2016. PubMed
Oligomerization of coronin: Implication on actin filament length in Leishmania. Cytoskeleton (Hoboken, N.J.), December 2015. PubMed